Skip to content
lifestyle.socialsinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Daniel J. Edelman Inc. dba Edelman on behalf of itself and its Affiliates
ZeroToOne.AI Acquires GroundTruth to Deploy at Scale an AI Driven Predictive Intelligence Platform for Enterprise Decision Systems
May 21, 2026
Allegra® Returns to Andretti Global as Primary Partner for Marcus Ericsson
May 21, 2026
The Reynolds Kitchens® Brand Turns Any Countertop into a No-Mess Workspace with New Countertop Prep Paper
May 21, 2026
WHITE CLAW® OPENS A $1 MILLION BAR TAB, SO FANS CAN CALL A TIME OUT ON TIRED AND EXPECTED DRINK ORDERS DURING BASKETBALL’S BIGGEST TOURNAMENT
May 20, 2026
The Zoo Pals™ Crew Is Back — Now on New Hefty® Press to Close Sandwich and Snack Bags
May 20, 2026
TACO BELL® DEBUTS BOLD NEW CHICKEN INNOVATIONS REMIXING TWO FAN-FAVORITE FORMS
May 20, 2026
DOVE EMPOWERS WOMEN TO TREAT THEIR HAIR LIKE A WORK OF ART WITH LIMITED-EDITION “THE ART OF REPAIR” COLLECTION, AVAILABLE EXCLUSIVELY AT WALMART
May 20, 2026
Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer
May 19, 2026
Johnson & Johnson investigational co-antibody therapy JNJ-4804 shows potential to raise the bar for clinical efficacy in treating refractory inflammatory bowel disease
May 7, 2026
Johnson & Johnson study shows TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate efficacy in perianal fistulizing Crohn’s disease
May 7, 2026
←
Previous Page
1
2
3
4
…
10
Next Page
→